Zhang W, Wu S, Liu J, Zhang X, Ma X, Yang C, et al. Metastasis patterns and prognosis in young breast cancer patients: a SEER database analysis. Front Oncol. 2022;12: 872862.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mehraj U, Mushtaq U, Mir MA, Saleem A, Macha MA, Lone MN, et al., editors. Chemokines in triple-negative breast cancer heterogeneity: new challenges for clinical implications. Semin Cancer Biol; 2022: Elsevier.

Mehraj U, Sofi S, Alshehri B, Mir MA. Expression pattern and prognostic significance of CDKs in breast cancer: an integrated bioinformatic study. Cancer Biomark. 2022;34(3):505–19.

Article  CAS  PubMed  Google Scholar 

Boyle P, Levin B. World cancer report 20082008.

Stingl J, Caldas C. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer. 2007;7(10):791–9.

Article  CAS  PubMed  Google Scholar 

Malhotra GK, Zhao X, Band H, Band V. Histological, molecular and functional subtypes of breast cancers. Cancer Biol Ther. 2010;10(10):955–60.

Article  PubMed  PubMed Central  Google Scholar 

Rakha EA, Teoh TK, Lee AH, Nolan CC, Ellis IO, Green AR. Further evidence that E-cadherin is not a tumour suppressor gene in invasive ductal carcinoma of the breast: an immunohistochemical study. Histopathology. 2013;62(5):695–701.

Article  PubMed  Google Scholar 

Ch’ng ES, Tuan Sharif SE, Jaafar H. In human invasive breast ductal carcinoma, tumor stromal macrophages and tumor nest macrophages have distinct relationships with clinicopathological parameters and tumor angiogenesis. Virchows Arch. 2013;462:257–67.

Article  PubMed  Google Scholar 

Baretta Z, Guindalini RSC, Khramtsova G, Olopade OI. Resistance to trastuzumab in HER2-positive mucinous invasive ductal breast carcinoma. Clin Breast Cancer. 2013;13(2):156–8.

Article  CAS  PubMed  Google Scholar 

Zheng J, Alsaadi T, Blaichman J, Xie X, Omeroglu A, Meterissian S, Mesurolle B. Invasive ductal carcinoma of the breast: correlation between tumor grade determined by ultrasound-guided core biopsy and surgical pathology. Am J Roentgenol. 2013;200(1):W71–4.

Article  Google Scholar 

Currie MJ, Beardsley BE, Harris GC, Gunningham SP, Dachs GU, Dijkstra B, et al. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity. Hum Pathol. 2013;44(3):402–11.

Article  CAS  PubMed  Google Scholar 

Aghi M, Kiehl T-R, Brisman JL. Breast adenocarcinoma metastatic to epidural cervical spine meningioma: case report and review of the literature. J Neurooncol. 2005;75:149–55.

Article  PubMed  Google Scholar 

Eheman CR, Shaw KM, Ryerson AB, Miller JW, Ajani UA, White MC. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999–2004. Cancer Epidemiol Biomark Prev. 2009;18(6):1763–9.

Article  Google Scholar 

Makki J. Diversity of breast carcinoma: histological subtypes and clinical relevance. Clin Med Insights Pathol. 2015;8:S31563.

Article  Google Scholar 

Huober J, Gelber S, Goldhirsch A, Coates A, Viale G, Öhlschlegel C, et al. Prognosis of medullary breast cancer: analysis of 13 International Breast Cancer Study Group (IBCSG) trials. Ann Oncol. 2012;23(11):2843–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lobbezoo D, Truin W, Voogd A, Roumen R, Vreugdenhil G, Dercksen MW, et al. The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches. Oncotarget. 2016;7(20):29412.

Article  PubMed  PubMed Central  Google Scholar 

Thomassen M, Tan Q, Kruse TA. Gene expression meta-analysis identifies metastatic pathways and transcription factors in breast cancer. BMC Cancer. 2008;8:1–12.

Article  Google Scholar 

Mortazavi SS, Bahmanpour Z, Daneshmandpour Y, Roudbari F, Sheervalilou R, Kazeminasab S, Emamalizadeh B. An updated overview and classification of bioinformatics tools for MicroRNA analysis, which one to choose? Comput Biol Med. 2021;134: 104544.

Article  CAS  PubMed  Google Scholar 

Mulrane L, McGee SF, Gallagher WM, O’Connor DP. miRNA dysregulation in breast cancer. Can Res. 2013;73(22):6554–62.

Article  CAS  Google Scholar 

Petri BJ, Klinge CM. Regulation of breast cancer metastasis signaling by miRNAs. Cancer Metastasis Rev. 2020;39(3):837–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wu M, Li Q, Wang H. Identification of novel biomarkers associated with the prognosis and potential pathogenesis of breast cancer via integrated bioinformatics analysis. Technol Cancer Res Treat. 2021;20:1533033821992081.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kulasingam V, Diamandis EP. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat Clin Pract Oncol. 2008;5(10):588–99.

Article  CAS  PubMed  Google Scholar 

Castillo D, Gálvez JM, Herrera LJ, Román BS, Rojas F, Rojas I. Integration of RNA-Seq data with heterogeneous microarray data for breast cancer profiling. BMC Bioinform. 2017;18:1–15.

Article  Google Scholar 

Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics. 2012;28(6):882–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, et al. Gene ontology: tool for the unification of biology. Nat Genet. 2000;25(1):25–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27–30.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139–40.

Article  CAS  PubMed  Google Scholar 

Esfandi F, Taheri M, Omrani MD, Shadmehr MB, Arsang-Jang S, Shams R, Ghafouri-Fard S. Expression of long non-coding RNAs (lncRNAs) has been dysregulated in non-small cell lung cancer tissues. BMC Cancer. 2019;19:1–17.

Article  Google Scholar 

Li J-H, Liu S, Zhou H, Qu L-H, Yang J-H. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(D1):D92–7.

Article  CAS  PubMed  Google Scholar 

Karagkouni D, Paraskevopoulou MD, Chatzopoulos S, Vlachos IS, Tastsoglou S, Kanellos I, et al. DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions. Nucleic Acids Res. 2018;46(D1):D239–45.

Article  CAS  PubMed  Google Scholar 

Chou C-H, Shrestha S, Yang C-D, Chang N-W, Lin Y-L, Liao K-W, et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 2018;46(D1):D296–302.

Article  CAS  PubMed  Google Scholar 

Hobert O. Gene regulation by transcription factors and microRNAs. Science. 2008;319(5871):1785–6.

Article  CAS  PubMed  Google Scholar 

Yoo M, Shin J, Kim J, Ryall KA, Lee K, Lee S, et al. DSigDB: drug signatures database for gene set analysis. Bioinformatics. 2015;31(18):3069–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wirapati P, Sotiriou C, Kunkel S, Farmer P, Pradervand S, Haibe-Kains B, et al. Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res. 2008;10:1–11.